Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 261352, 7 pages
http://dx.doi.org/10.1155/2011/261352
Review Article

Engraftment of Insulin-Producing Cells from Porcine Islets in Non-Immune-Suppressed Rats or Nonhuman Primates Transplanted Previously with Embryonic Pig Pancreas

George M. O'Brien Center for Kidney Disease Research, Departments of Medicine, and Cell Biology and Physiology, The Washington University School of Medicine, St. Louis, MO 63110, USA

Received 17 May 2011; Revised 2 July 2011; Accepted 2 July 2011

Academic Editor: Thierry Berney

Copyright © 2011 Marc R. Hammerman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Hammerman, “Xenotransplantation of embryonic pig kidney or pancreas to replace the function of mature organs,” Journal of Transplantation, Article ID 501749, 2011. View at Publisher · View at Google Scholar
  2. K. Brands, E. Colvin, L. J. Williams, R. Wang, R. B. Lock, and B. E. Tuch, “Reduced immunogenicity of first-trimester human fetal pancreas,” Diabetes, vol. 57, no. 3, pp. 627–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Rogers, F. Chen, M. Talcott, and M. R. Hammerman, “Islet cell engraftment and control of diabetes in rats after transplantation of pig pancreatic anlagen,” American Journal of Physiology, vol. 286, no. 4, pp. E502–E509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Rogers, H. Liapis, and M. R. Hammerman, “Normalization of glucose post-transplantation of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining anlagen prior to embryonic day 35,” Transplant Immunology, vol. 14, no. 2, pp. 67–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. A. Rogers, F. Chen, M. Talcott, H. Liapis, and M. R. Hammerman, “Glucose tolerance normalization following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic ZDF rats,” Transplant Immunology, vol. 16, no. 3-4, pp. 176–184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Rogers, F. Chen, M. R. Talcott et al., “Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques,” Xenotransplantation, vol. 14, no. 6, pp. 591–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Rogers, T. Mohanakumar, H. Liapis, and M. R. Hammerman, “Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats,” American Journal of Pathology, vol. 177, no. 2, pp. 854–864, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Rogers, R. Tripathi, T. Mohanakumar et al., “Engraftment of cells from porcine islets of Langerhans following transplantation of pig pancreatic primordia in non-immune suppressed diabetic rhesus macaques,” Organogenesis, vol. 7, no. 3, 2011. View at Google Scholar
  9. S. Eventov-Friedman, H. Katchman, E. Shezen et al., “Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2928–2933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Eventov-Friedman, D. Tchorsh, H. Katchman et al., “Embryonic pig pancreatic tissue transplantation for the treatment of diabetes,” PLoS Medicine, vol. 3, no. 7, pp. 1165–1177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Tchorsh-Yutsis, G. Hecht, A. Aronovich et al., “Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression,” Diabetes, vol. 58, no. 7, pp. 1585–1594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Hecht, S. Eventov-Friedman, C. Rosen et al., “Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8659–8664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Sachs, “The pig as a potential xenograft donor,” Veterinary Immunology and Immunopathology, vol. 43, no. 1–3, pp. 185–191, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Ibrahim, J. Busch, M. Awwad, R. Wagner, K. Wells, and D. K. C. Cooper, “Selected physiologic compatibilities and incompatibilities between human and porcine organ systems,” Xenotransplantation, vol. 13, no. 6, pp. 488–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Hathout, J. Lakey, and J. Shapiro, “Islet transplant: an option for childhood diabetes?” Archives of Disease in Childhood, vol. 88, no. 7, pp. 591–595, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Dufrane, R. M. Goebbels, A. Saliez, Y. Guiot, and P. Gianello, “Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept,” Transplantation, vol. 81, no. 9, pp. 1345–1353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Kirchhof, S. Shibata, M. Wijkstrom et al., “Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection,” Xenotransplantation, vol. 11, no. 5, pp. 396–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Cantarovich, G. Blancho, N. Potiron et al., “Rapid failure of pig islet transplantation in non human primates,” Xenotransplantation, vol. 9, no. 1, pp. 25–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. Hering, M. Wijkstrom, M. L. Graham et al., “Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates,” Nature Medicine, vol. 12, no. 3, pp. 301–303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Cardona, G. S. Korbutt, Z. Milas et al., “Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways,” Nature Medicine, vol. 12, no. 3, pp. 304–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. van der Windt, R. Bottino, A. Casu et al., “Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets,” American Journal of Transplantation, vol. 9, no. 12, pp. 2716–2726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. van der Windt, G. J. Echeverri, J. N. M. Ijzermans, and D. K. C. Cooper, “The choice of anatomical site for islet transplantation,” Cell Transplantation, vol. 17, no. 9, pp. 1005–1014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Schroeder, C. E. Marroquin, and P. C. Kuo, “Tolerance and the “Holy Grail” of transplantation,” Journal of Surgical Research, vol. 111, no. 1, pp. 109–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Eloy, K. Haffen, M. Kedinger, and J. F. Grenier, “Chick embryo pancreatic transplants reverse experimental diabetes of rats,” Journal of Clinical Investigation, vol. 64, no. 2, pp. 361–373, 1979. View at Google Scholar · View at Scopus
  25. E. J. Abraham, S. Kodama, J. C. Lin, M. Ubeda, D. L. Faustman, and J. F. Habener, “Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice,” American Journal of Pathology, vol. 164, no. 3, pp. 817–830, 2004. View at Google Scholar · View at Scopus
  26. A. A. Rossini, D. L. Greiner, and J. P. Mordes, “Induction of immunologic tolerance for transplantation,” Physiological Reviews, vol. 79, no. 1, pp. 99–141, 1999. View at Google Scholar · View at Scopus
  27. M. R. Hammerman, “Organogenetic tolerance,” Organogenesis, vol. 6, no. 4, pp. 270–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Macpherson and K. Smith, “Mesenteric lymph nodes at the center of immune anatomy,” Journal of Experimental Medicine, vol. 203, no. 3, pp. 497–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. I. N. Crispe, “Hepatic T cells and liver tolerance,” Nature Reviews Immunology, vol. 3, no. 1, pp. 51–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Worbs, U. Bode, S. Yan et al., “Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells,” Journal of Experimental Medicine, vol. 203, no. 3, pp. 519–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Matsunaga and A. Rahman, “In search of the origin of the thymus: the thymus and GALT may be evolutionarily related,” Scandinavian Journal of Immunology, vol. 53, no. 1, pp. 1–6, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. H. Youson and A. A. Al-Mahrouki, “Ontogenetic and phylogenetic development of the endocrine pancreas (islet organ) in fishes,” General and Comparative Endocrinology, vol. 116, no. 3, pp. 303–335, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Jansen, H. A. M. Voorbij, P. H. M. Jeucken, G. J. Bruining, H. Hooijkaas, and H. A. Drexhage, “An immunohistochemical study on organized lymphoid cell infiltrates in fetal and neonatal pancreases. A comparison with similar infiltrates found in the pancreas of a diabetic infant,” Autoimmunity, vol. 15, no. 1, pp. 31–38, 1993. View at Google Scholar
  34. S. J. Turley, J. W. Lee, N. Dutton-Swain, D. Mathis, and C. Benoist, “Endocrine self and gut non-self intersect in the pancreatic lymph nodes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 49, pp. 17729–17733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Chen, J. I. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner, “Peripheral deletion of antigen-reactive T cells in oral tolerance,” Nature, vol. 376, no. 6536, pp. 177–180, 1995. View at Google Scholar · View at Scopus
  36. T. W. Spahn, H. L. Weiner, P. D. Rennert et al., “Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches,” European Journal of Immunology, vol. 32, no. 4, pp. 1109–1113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Harada, K. Matsunaga, Y. Oguchi et al., “The involvement of transforming growth factor β in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT),” Cancer Research, vol. 55, no. 24, pp. 6146–6151, 1995. View at Google Scholar · View at Scopus
  38. M. Flanagan, S. Jain, and J. G. Michael, “Breaking of oral tolerance by an encapsulated antigen,” Annals of the New York Academy of Sciences, vol. 778, pp. 373–375, 1996. View at Publisher · View at Google Scholar · View at Scopus